Neurocrine Biosciences (NBIX) Return on Capital Employed [ROCE] (2009 - 2026)
Neurocrine Biosciences' Return on Capital Employed [ROCE] came in at 19.68% for Q3 2026, up 3.68 percentage points from 16.00% a year earlier and up 1.01 percentage points from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Return on Capital Employed [ROCE] (2009 - 2026) Analysis & Trends
For FY2025, Neurocrine Biosciences' Return on Capital Employed [ROCE] was 18.04%, down 1.12 percentage points from FY2024.
- Return on Capital Employed [ROCE] carries a five-year change of +5.82 percentage points (FY2020 to FY2025).
- Going back by year, Return on Capital Employed [ROCE] was 19.16% in FY2024 (+7.52 pp), 11.64% in FY2023 (-3.15 pp), 14.80% in FY2022 (+8.61 pp) and 6.18% in FY2021 (-6.04 pp).
- The five-year range for quarterly Return on Capital Employed [ROCE] is 3.69% (Q2 2022) to 20.04% (Q1 2026).
- Year-over-year, Return on Capital Employed [ROCE] has increased for three consecutive quarters, with an average year-over-year change of +1.22 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q1 2024 (a gain of 10.91 percentage points), and the weakest in Q4 2021 (a drop of 5.68 percentage points).
- Business Quant data shows NBIX's Return on Capital Employed [ROCE] at 18.67% (Q2 2026), 20.04% (Q1 2026) and 16.71% (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 35.41% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 21.60% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.65% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.91% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 17.37% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -6.15% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 11.32% |
| 10 | Neurocrine Biosciences | 17.13 Bn | 13.21 Bn | 1.10 Bn | 19.68% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 19.68% |
| Jun 30, 2026 | 18.67% |
| Mar 31, 2026 | 20.04% |
| Dec 31, 2025 | 16.71% |
| Sep 30, 2025 | 16.00% |
| Jun 30, 2025 | 15.27% |
| Mar 31, 2025 | 15.56% |
| Dec 31, 2024 | 18.29% |
| Sep 30, 2024 | 19.36% |
| Jun 30, 2024 | 17.93% |
| Mar 31, 2024 | 17.53% |
| Dec 31, 2023 | 10.48% |
| Sep 30, 2023 | 10.00% |
| Jun 30, 2023 | 7.91% |
| Mar 31, 2023 | 6.62% |
| Dec 31, 2022 | 14.49% |
| Sep 30, 2022 | 6.88% |
| Jun 30, 2022 | 3.69% |
| Mar 31, 2022 | 3.99% |
| Dec 31, 2021 | 5.70% |
API Access
Neurocrine Biosciences Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();